Market Tracker

04/27 4:45pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

31.44
Delayed Data
As of Apr 27
 -1.68 / -5.07%
Today’s Change
28.26
Today|||52-Week Range
45.45
-23.07%
Year-to-Date

Today’s Trading

Previous close33.12
Today’s open33.32
Day’s range31.21 - 33.38
Volume707,031
Average volume (3 months)746,812
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-158.74%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+19.34%
P/E ratio75.7
Price/Sales4.19
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc-1.30-5.59%
ZIOPZIOPHARM Oncology In...-1.00-9.25%
TTPHTetraphase Pharmaceu...-2.29-5.72%
MACKMerrimack Pharmaceut...-1.14-8.53%
Data as of 4:00pm ET, 04/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts